Liubov R. Stetsiuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liubov R. Stetsiuk has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Borys M. Todurov
Shupyk National Healthcare University of Ukraine, Kyiv
5 shared publications - Igor Mokryk
Heart Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
4 shared publications - Ihor O. Stetsyuk
Heart Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
4 shared publications - Oleg V. Zelenchuk
Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine; Heart Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
3 shared publications - A. O. Kipot
The Heart Institute of the Ministry of Health of Ukraine, Bratyslavska str, 5A, Kyiv, 02660; Dnipro State Medical University ² Volodymyra Vernadskoho str, 9, Dnipro, 49044
2 shared publications - Vitaly Demyanchuk
Heart Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
2 shared publications
Latest Publications
- Open Access
- 30 December 2025
- Published by Dnipro State Medical University
- Vol. 30 (4) , 93-97
High-risk thrombosis of a mechanical aortic valve: successful thrombolysis as a bridge or an alternative to surgery
Thrombosis of a mechanical aortic valve prosthesis is a rare, yet potentially life-threatening complication that demands urgent recognition, rapid diagnostic evaluation, and immediate therapeutic intervention. We describe a detailed clinical case of a 52-year-old male patient who developed critical thrombosis of a mechanical aortic valve prosthesis despite maintaining an adequate and well-controlled anticoagulant regimen. The patient presented with profound hemodynamic instability, markedly reduced ejection fraction, and clinical manifestations consistent with acute decompensated heart failure. On physical and instrumental examination, his condition corresponded to ASA class IV, with a calculated surgical risk of EuroSCORE II=17.28%, indicating an extremely high perioperative mortality risk. Considering both the elevated risk of surgical re-intervention and the rapidly worsening heart failure, the multidisciplinary team decided to initiate systemic thrombolytic therapy as a life-saving alternative. Thrombolysis was performed according to an accelerated protocol using intravenous alteplase at a total dose of 100 mg. Within the first hour of infusion, echocardiography revealed a clear positive trend – restoration of leaflet mobility, a notable reduction in the transprosthetic gradient, and significant improvement in myocardial contractility. Subsequent management continued in the intensive care unit with careful hemodynamic and laboratory monitoring. The patient was discharged on the eighth day in a stable condition, free of complications. Follow-up echocardiography two months later confirmed normal and sustained function of the mechanical prosthesis. This case illustrates the high efficacy of systemic thrombolysis as a viable and guideline-supported (ESC/EACTS 2021, Class I, Level B) therapeutic option when surgical treatment is contraindicated or technically impossible.
- 30 December 2025
- Published by Dnipro State Medical University
- Vol. 30 (4) , 93-97
Open AccessHigh-risk thrombosis of a mechanical aortic valve: successful thrombolysis as a bridge or an alternative to surgery
Thrombosis of a mechanical aortic valve prosthesis is a rare, yet potentially life-threatening complication that demands urgent recognition, rapid diagnostic evaluation, and immediate therapeutic intervention. We describe a detailed clinical case of a 52-year-old male patient who developed critical thrombosis of a mechanical aortic valve prosthesis despite maintaining an adequate and well-controlled anticoagulant regimen. The patient presented with profound hemodynamic instability, markedly reduced ejection fraction, and clinical manifestations consistent with acute decompensated heart failure. On physical and instrumental examination, his condition corresponded to ASA class IV, with a calculated surgical risk of EuroSCORE II=17.28%, indicating an extremely high perioperative mortality risk. Considering both the elevated risk of surgical re-intervention and the rapidly worsening heart failure, the multidisciplinary team decided to initiate systemic thrombolytic therapy as a life-saving alternative. Thrombolysis was performed according to an accelerated protocol using intravenous alteplase at a total dose of 100 mg. Within the first hour of infusion, echocardiography revealed a clear positive trend – restoration of leaflet mobility, a notable reduction in the transprosthetic gradient, and significant improvement in myocardial contractility. Subsequent management continued in the intensive care unit with careful hemodynamic and laboratory monitoring. The patient was discharged on the eighth day in a stable condition, free of complications. Follow-up echocardiography two months later confirmed normal and sustained function of the mechanical prosthesis. This case illustrates the high efficacy of systemic thrombolysis as a viable and guideline-supported (ESC/EACTS 2021, Class I, Level B) therapeutic option when surgical treatment is contraindicated or technically impossible.
- Open Access
- 25 January 2025
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Science and innovation
- Vol. 21 (1) , 104-111
Glutaraldehyde-Treated Autologous Pericardium in Aortic Valve Reconstruction: an Optimal Material for Innovation Techniques. Review of the Literature
Introduction. Reconstructive operations on the aortic valve (AV) offer several advantages over standard AV replacement with mechanical or biological prostheses. This approach has allowed patients to avoid the adverse effects of long-term antithrombotic therapy. Furthermore, it has preserved the natural mobility of the left ventricular outflow tract, resulting in improved hemodynamics across the valve. Materials for reconstruction are often readily available, making the method economically attractive.Problem Statement. Autologous pericardium is the most commonly used material in AV reconstruction. Glutaraldehyde treatment of autologous pericardium (GTAP) has provided tissue with enhanced mechanical properties and reduced thrombogenicity. However, the long-term degeneration of biological tissues used in AV surgery has remained a concern despite glutaraldehyde treatment.Purpose. This study has aimed to evaluate the current status and future prospects for the use of GTAP in reconstructive AV surgery.Materials and Methods. A literature search has been conducted using PubMed, Web of Science, and the Google search engine. All studies on GA-fixed pericardial tissue published up to March 2023 have been identified. A total of 165 articles have been initially retrieved, of which 20 relevant studies are included in this review. Results. GTAP has demonstrated excellent elasticity and surgical handling characteristics. It has enabled complex AV reconstructions with sustained immediate transvalvular hemodynamics. Degeneration and calcification rates of GTAP have been comparable to those observed in existing biological prostheses.Conclusions. GTAP off ers signifi cant potential for advancing techniques in aortic valve pathology correction. It is cost-effective, readily available, and facilitates effective valve reconstruction. However, aggressive prophylaxis for infective endocarditis remains mandatory in the postoperative period. Further multicenter studies with larger cohorts are essential to better delineate the long-term prospects and limitations of GTAP in AV surgery.
- 25 January 2025
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Science and innovation
- Vol. 21 (1) , 104-111
Open AccessGlutaraldehyde-Treated Autologous Pericardium in Aortic Valve Reconstruction: an Optimal Material for Innovation Techniques. Review of the Literature
Introduction. Reconstructive operations on the aortic valve (AV) offer several advantages over standard AV replacement with mechanical or biological prostheses. This approach has allowed patients to avoid the adverse effects of long-term antithrombotic therapy. Furthermore, it has preserved the natural mobility of the left ventricular outflow tract, resulting in improved hemodynamics across the valve. Materials for reconstruction are often readily available, making the method economically attractive.Problem Statement. Autologous pericardium is the most commonly used material in AV reconstruction. Glutaraldehyde treatment of autologous pericardium (GTAP) has provided tissue with enhanced mechanical properties and reduced thrombogenicity. However, the long-term degeneration of biological tissues used in AV surgery has remained a concern despite glutaraldehyde treatment.Purpose. This study has aimed to evaluate the current status and future prospects for the use of GTAP in reconstructive AV surgery.Materials and Methods. A literature search has been conducted using PubMed, Web of Science, and the Google search engine. All studies on GA-fixed pericardial tissue published up to March 2023 have been identified. A total of 165 articles have been initially retrieved, of which 20 relevant studies are included in this review. Results. GTAP has demonstrated excellent elasticity and surgical handling characteristics. It has enabled complex AV reconstructions with sustained immediate transvalvular hemodynamics. Degeneration and calcification rates of GTAP have been comparable to those observed in existing biological prostheses.Conclusions. GTAP off ers signifi cant potential for advancing techniques in aortic valve pathology correction. It is cost-effective, readily available, and facilitates effective valve reconstruction. However, aggressive prophylaxis for infective endocarditis remains mandatory in the postoperative period. Further multicenter studies with larger cohorts are essential to better delineate the long-term prospects and limitations of GTAP in AV surgery.
- Open Access
- 1 January 2025
- Published by Publishing House Helvetica (Publications)
- No. 1,p. 48-52
ANALYSIS OF THE OCCURRENCE AND COURSE OF SECONDARY ISCHEMIC MITRAL REGURGITATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Introduction. One of the complications due to myocardial infarction is secondary mitral regurgitation, which occur from left atrial or left ventricular (LV) dysfunction or after the rupture of the mitral subvalvular apparatus. Ischemic secondary mitral regurgitation occurs in 7–32% of cases according to various literature sources. Due to its high frequency, it requires more detailed study. The aim – to study the frequency of secondary ischemic mitral regurgitation in patients with acute myocardial infarction based on angiography data and the time before revascularization. Materials and methods. The study included 149 patients with acute myocardial infarction. The following methods were used: general clinical examination, laboratory diagnostics, echocardiography, electrocardiography, and coronary angiography. Results. Among patients with mitral regurgitation, infarct-dependent involvement of the right coronary artery was predominant – 46 (45.54%) patients, p = 0.016, followed by the circumflex branch of the left coronary artery – 34 (33.66%) patients, p = 0.015. A higher percentage of multivessel disease was observed in patients with mitral regurgitation – 57 (56.44%), p = 0.031. Moreover, higher-grade ischemic mitral regurgitation was more frequently observed in patients who underwent revascularization > 12 hours after the onset of symptoms. Conclusions. Secondary ischemic mitral regurgitation in acute myocardial infarction was more commonly diagnosed in patients with infarct caused by right coronary artery lesions, followed by the circumflex branch of the left coronary artery. According to the obtained data, a longer duration from the onset of myocardial infarction symptoms tends to increase the degree of mitral regurgitation. Метою дослідження було вивчення частоти виникнення вторинної ішемічної мітральної регургітації у пацієнтів з гострим інфарктом міокарда відповідно до даних ангіографії та часу до реваскуляризації. У пацієнтів з мітральною регургітацією переважало інфаркт-залежне ураження правої коронарної артерії (ПКА) та огинаючої гілки лівої коронарної артерії (ОГ ЛКА). Виявлено вищий відсоток багатосудинного ураження у пацієнтів з мітральною регургітацією. Ішемічна мітральна регургітація більшого ступеня частіше спостерігалася у пацієнтів, у яких реваскуляризація відбулася більше ніж через 12 годин після початку симптомів. Висновки. Інфаркт-залежне ураження ПКА та ОГ ЛКА частіше зумовлює виникнення вторинної ішемічної мітральної регургітації у хворих із гострим інфарктом. Більш тривалий час з моменту початку симптомів інфаркту міокарда має тенденцію впливати на збільшення ступеня ішемічної мітральної регургітації.
- 1 January 2025
- Published by Publishing House Helvetica (Publications)
- No. 1,p. 48-52
Open AccessANALYSIS OF THE OCCURRENCE AND COURSE OF SECONDARY ISCHEMIC MITRAL REGURGITATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Introduction. One of the complications due to myocardial infarction is secondary mitral regurgitation, which occur from left atrial or left ventricular (LV) dysfunction or after the rupture of the mitral subvalvular apparatus. Ischemic secondary mitral regurgitation occurs in 7–32% of cases according to various literature sources. Due to its high frequency, it requires more detailed study. The aim – to study the frequency of secondary ischemic mitral regurgitation in patients with acute myocardial infarction based on angiography data and the time before revascularization. Materials and methods. The study included 149 patients with acute myocardial infarction. The following methods were used: general clinical examination, laboratory diagnostics, echocardiography, electrocardiography, and coronary angiography. Results. Among patients with mitral regurgitation, infarct-dependent involvement of the right coronary artery was predominant – 46 (45.54%) patients, p = 0.016, followed by the circumflex branch of the left coronary artery – 34 (33.66%) patients, p = 0.015. A higher percentage of multivessel disease was observed in patients with mitral regurgitation – 57 (56.44%), p = 0.031. Moreover, higher-grade ischemic mitral regurgitation was more frequently observed in patients who underwent revascularization > 12 hours after the onset of symptoms. Conclusions. Secondary ischemic mitral regurgitation in acute myocardial infarction was more commonly diagnosed in patients with infarct caused by right coronary artery lesions, followed by the circumflex branch of the left coronary artery. According to the obtained data, a longer duration from the onset of myocardial infarction symptoms tends to increase the degree of mitral regurgitation. Метою дослідження було вивчення частоти виникнення вторинної ішемічної мітральної регургітації у пацієнтів з гострим інфарктом міокарда відповідно до даних ангіографії та часу до реваскуляризації. У пацієнтів з мітральною регургітацією переважало інфаркт-залежне ураження правої коронарної артерії (ПКА) та огинаючої гілки лівої коронарної артерії (ОГ ЛКА). Виявлено вищий відсоток багатосудинного ураження у пацієнтів з мітральною регургітацією. Ішемічна мітральна регургітація більшого ступеня частіше спостерігалася у пацієнтів, у яких реваскуляризація відбулася більше ніж через 12 годин після початку симптомів. Висновки. Інфаркт-залежне ураження ПКА та ОГ ЛКА частіше зумовлює виникнення вторинної ішемічної мітральної регургітації у хворих із гострим інфарктом. Більш тривалий час з моменту початку симптомів інфаркту міокарда має тенденцію впливати на збільшення ступеня ішемічної мітральної регургітації.
- Open Access
- 29 November 2024
- Published by Chetverta Khvylia in Cardiac Surgery and Interventional Cardiology
- Vol. 13 (3) , 40-44
Mid-term outcome and quality of life after Bentall procedure: single-center experience
The aim – to evaluate the mid-term results and quality of life of patients who underwent Bentall procedure.Materials and methods. The research included 55 patients who underwent planned surgical treatment at the Heart Institute of Ministry of Health of Ukraine from 2015 to 2023. The mean age of the 55 patients (53 (96.36 %) males), who underwent the Bentall procedure (composite graft replacement of the aortic root), was 52.36 ± 1.56 years. We analyzed basic characteristics of the patients, intraoperative and postoperative data. The quality of life was assessed before and in the mid-term period after operations by the Medical Outcomes Study Short Form 36 (MOS SF-36) questionnaire.Results. An average duration of the follow-up period was (3.61 ± 0.28) (СІ 3.05–4.16) years ranging from 1.0 to 9.0 years. Overall, in-hospital mortality and 30-day mortality was 1.89 % (n = 1). The only case of death was caused by the acute respiratory distress syndrome. The 5-year survival rate was 94.61 ± 3.10 % for all patients. It is reasonable to say that all 3 cases of death were due to a non-cardiac cause, i.e. stroke, malignancy and acute abdomen. The average duration of the operations was 244.48 ± 7.67 minutes, the total duration of artificial blood circulation was 138.73 ± 6.47 minutes, aorta clamping time – 95.82 ± 4.79 minutes. The mean duration of hospital staying was 16.98 ± 0.91 days, intensive care unit – 4.84 ± 0.33 days. The number of patients extubated up to 8 hours after surgery was 41 (74.55 %) patients. The operation significantly improved parameters of the quality of life. Conclusions. Patients after Bentall procedure have low overall in-hospital mortality and 30-day mortality (1 (1.89 %)). The 5-year survival rate was 94.61 ± 3.10 %. All three case of death during follow-up period were due to non-cardiac causes. Excellent mid-term results prove that Bentall procedure must be a routine surgery for patients with aortic root aneurysm, mixed aortic valve pathology and anatomically altered aortic valve leaflets. The operation significantly improved quality of life of patients in all domains.
- 29 November 2024
- Published by Chetverta Khvylia in Cardiac Surgery and Interventional Cardiology
- Vol. 13 (3) , 40-44
Open AccessMid-term outcome and quality of life after Bentall procedure: single-center experience
The aim – to evaluate the mid-term results and quality of life of patients who underwent Bentall procedure.Materials and methods. The research included 55 patients who underwent planned surgical treatment at the Heart Institute of Ministry of Health of Ukraine from 2015 to 2023. The mean age of the 55 patients (53 (96.36 %) males), who underwent the Bentall procedure (composite graft replacement of the aortic root), was 52.36 ± 1.56 years. We analyzed basic characteristics of the patients, intraoperative and postoperative data. The quality of life was assessed before and in the mid-term period after operations by the Medical Outcomes Study Short Form 36 (MOS SF-36) questionnaire.Results. An average duration of the follow-up period was (3.61 ± 0.28) (СІ 3.05–4.16) years ranging from 1.0 to 9.0 years. Overall, in-hospital mortality and 30-day mortality was 1.89 % (n = 1). The only case of death was caused by the acute respiratory distress syndrome. The 5-year survival rate was 94.61 ± 3.10 % for all patients. It is reasonable to say that all 3 cases of death were due to a non-cardiac cause, i.e. stroke, malignancy and acute abdomen. The average duration of the operations was 244.48 ± 7.67 minutes, the total duration of artificial blood circulation was 138.73 ± 6.47 minutes, aorta clamping time – 95.82 ± 4.79 minutes. The mean duration of hospital staying was 16.98 ± 0.91 days, intensive care unit – 4.84 ± 0.33 days. The number of patients extubated up to 8 hours after surgery was 41 (74.55 %) patients. The operation significantly improved parameters of the quality of life. Conclusions. Patients after Bentall procedure have low overall in-hospital mortality and 30-day mortality (1 (1.89 %)). The 5-year survival rate was 94.61 ± 3.10 %. All three case of death during follow-up period were due to non-cardiac causes. Excellent mid-term results prove that Bentall procedure must be a routine surgery for patients with aortic root aneurysm, mixed aortic valve pathology and anatomically altered aortic valve leaflets. The operation significantly improved quality of life of patients in all domains.
- Open Access
- 8 May 2024
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 3,p. 21-26
QUALITY OF LIFE OF PATIENTS TREATED BY VALVE-SPARING AORTIC ROOT REPLACEMENT
The aim. To determine the effectiveness of David valve-preserving operation in comparison with Bentall operation based on the analysis of patients' quality of life after operations. Materials and methods. The study included 107 patients who underwent planned and urgent surgical treatment at the Heart Institute of the Ministry of Health of Ukraine from 2015 to 2023. The patients were divided into two groups depending on the type of surgical intervention: group A consisted of 53 patients (49,11±1,54 years; 47 (88,68%) males), who underwent the David procedure (valve-sparing replacement of aortic root and ascending aorta), group B – 55 patients (52,36±1,56 years; 53 (96,36%) males), who underwent Bentall surgery (replacement of the valve, root and ascending part of the aorta). The quality of life was assessed before the operation for each group, and in the long-term period after operation. The quality of life of the patients of both groups was compared. It was assessed using the Medical Outcomes Study Short Form 36 (MOS SF-36) questionnaire. Results. The obtained data indicated that the average preoperative values of quality of life indicators of patients of both groups with different types of aneurysm correction were significantly different from ideal health. The performed operations significantly improved the assessment of the quality of life. When comparing the quality of life in the remote period of the patients of both groups, the indicators were significantly better in group A. We noticed that the patients of group A had a significantly better psycho-social component, which probably influenced the assessment of other scales. Group A patients had statistically better all indicators of quality of life after surgery comparing with group B patients. Group B patients complained about the sound of the artificial aortic valve prosthesis, sometimes the occurrence of minor nosebleeds and the need for frequent visits of the doctor to monitor blood "thinning" indicators. Conclusions. The obtained results indicate a positive change in the quality of life in patients of both groups. When David operation is performed for aortic root and ascending aortic aneurysms, the quality of life is significantly better than in patients after Bentall operation. We recommend performing David operations at the highly specialized cardiac centers. Мета. Визначити ефективність клапанозберігаючої операції Девіда в порівнянні з операцією Бенталла на основі аналізу якості життя пацієнтів після операції. Матеріали та методи. Обстежено 107 пацієнтів, яким виконано планове та невідкладне оперативне лікування в ДУ «Інститут серця МОЗ України» з 2015 по 2023 рр. Залежно від виду оперативного втручання пацієнтів було розподілено на дві групи: групу А склали 53 пацієнти (49,11±1,54 років (47 (88,68%) чоловіків), яким виконано операцію Девіда (клапанозберігаюче протезування кореня аорти та висхідної аорти), група Б – 55 пацієнтів (52,36±1,56 років (53 (96,36%) чоловіки), яким виконано операцію Бенталла (заміна клапана, кореня та висхідної частини аорти). Якість життя оцінювали до операції для кожної групи, а також у віддалений період після операції. Порівнювали якість життя пацієнтів обох груп. Оцінювали якість життя за допомогою опитувальника Medical Outcomes Study Short Form 36 (MOS SF-36). Результати. Отримані дані свідчать про те, що середні доопераційні значення показників якості життя пацієнтів обох груп з різними видами корекції аневризми відрізнялися від ідеального стану здоров’я. Проведені операції значно покращили оцінку якості життя. При порівнянні якості життя у віддаленому періоді пацієнтів обох груп показники були достовірно кращими в групі А. Ми помітили, що пацієнти групи А мали достовірно кращий психосоціальний компонент, що, ймовірно, вплинуло на оцінку інших шкал. Пацієнти групи А мали статистично кращі всі показники якості життя після операції порівняно з пацієнтами групи Б. Пацієнти групи Б скаржилися на звук протезування штучного клапана аорти, інколи на появу незначних носових кровотеч і необхідність частого відвідування лікаря для контролю показників «розрідження» крові. Висновки. Отримані результати свідчать про позитивну зміну якості життя пацієнтів обох груп. При операції Девіда з приводу аневризми кореня аорти і висхідної аорти, якість життя значно краща, ніж у пацієнтів після операції Бенталла. Ми рекомендуємо...
- 8 May 2024
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 3,p. 21-26
Open AccessQUALITY OF LIFE OF PATIENTS TREATED BY VALVE-SPARING AORTIC ROOT REPLACEMENT
The aim. To determine the effectiveness of David valve-preserving operation in comparison with Bentall operation based on the analysis of patients' quality of life after operations. Materials and methods. The study included 107 patients who underwent planned and urgent surgical treatment at the Heart Institute of the Ministry of Health of Ukraine from 2015 to 2023. The patients were divided into two groups depending on the type of surgical intervention: group A consisted of 53 patients (49,11±1,54 years; 47 (88,68%) males), who underwent the David procedure (valve-sparing replacement of aortic root and ascending aorta), group B – 55 patients (52,36±1,56 years; 53 (96,36%) males), who underwent Bentall surgery (replacement of the valve, root and ascending part of the aorta). The quality of life was assessed before the operation for each group, and in the long-term period after operation. The quality of life of the patients of both groups was compared. It was assessed using the Medical Outcomes Study Short Form 36 (MOS SF-36) questionnaire. Results. The obtained data indicated that the average preoperative values of quality of life indicators of patients of both groups with different types of aneurysm correction were significantly different from ideal health. The performed operations significantly improved the assessment of the quality of life. When comparing the quality of life in the remote period of the patients of both groups, the indicators were significantly better in group A. We noticed that the patients of group A had a significantly better psycho-social component, which probably influenced the assessment of other scales. Group A patients had statistically better all indicators of quality of life after surgery comparing with group B patients. Group B patients complained about the sound of the artificial aortic valve prosthesis, sometimes the occurrence of minor nosebleeds and the need for frequent visits of the doctor to monitor blood "thinning" indicators. Conclusions. The obtained results indicate a positive change in the quality of life in patients of both groups. When David operation is performed for aortic root and ascending aortic aneurysms, the quality of life is significantly better than in patients after Bentall operation. We recommend performing David operations at the highly specialized cardiac centers. Мета. Визначити ефективність клапанозберігаючої операції Девіда в порівнянні з операцією Бенталла на основі аналізу якості життя пацієнтів після операції. Матеріали та методи. Обстежено 107 пацієнтів, яким виконано планове та невідкладне оперативне лікування в ДУ «Інститут серця МОЗ України» з 2015 по 2023 рр. Залежно від виду оперативного втручання пацієнтів було розподілено на дві групи: групу А склали 53 пацієнти (49,11±1,54 років (47 (88,68%) чоловіків), яким виконано операцію Девіда (клапанозберігаюче протезування кореня аорти та висхідної аорти), група Б – 55 пацієнтів (52,36±1,56 років (53 (96,36%) чоловіки), яким виконано операцію Бенталла (заміна клапана, кореня та висхідної частини аорти). Якість життя оцінювали до операції для кожної групи, а також у віддалений період після операції. Порівнювали якість життя пацієнтів обох груп. Оцінювали якість життя за допомогою опитувальника Medical Outcomes Study Short Form 36 (MOS SF-36). Результати. Отримані дані свідчать про те, що середні доопераційні значення показників якості життя пацієнтів обох груп з різними видами корекції аневризми відрізнялися від ідеального стану здоров’я. Проведені операції значно покращили оцінку якості життя. При порівнянні якості життя у віддаленому періоді пацієнтів обох груп показники були достовірно кращими в групі А. Ми помітили, що пацієнти групи А мали достовірно кращий психосоціальний компонент, що, ймовірно, вплинуло на оцінку інших шкал. Пацієнти групи А мали статистично кращі всі показники якості життя після операції порівняно з пацієнтами групи Б. Пацієнти групи Б скаржилися на звук протезування штучного клапана аорти, інколи на появу незначних носових кровотеч і необхідність частого відвідування лікаря для контролю показників «розрідження» крові. Висновки. Отримані результати свідчать про позитивну зміну якості життя пацієнтів обох груп. При операції Девіда з приводу аневризми кореня аорти і висхідної аорти, якість життя значно краща, ніж у пацієнтів після операції Бенталла. Ми рекомендуємо...
- Open Access
- 26 April 2024
- Published by Chetverta Khvylia in Cardiac Surgery and Interventional Cardiology
- Vol. 13 (1) , 62-67
Клапанозбережне протезування кореня аорти: результати операції Девіда І
The aim – to determine the long-term results and quality of life of patients who underwent David І valve-sparing operation.Materials and methods. The one-center study included 53 patients who underwent planned and urgent David I procedure (valve-sparing replacement of the aortic root and ascending aorta) from 2015 to 2023. The mean age of the 53 patients (among them, 47 (88.68 %) males) was 49.11 ± 1.54 years. We analyzed basic characteristics of the patients, intraoperative and postoperative data. The quality of life was assessed before and in the long-term period after operations by the Medical Outcomes Study Short Form 36 (MOS SF-36) questionnaire.Results and discussion. An average duration of the follow-up period was 2.59 ± 0.27 years ranging from 1.0 to 9.0 years. Overall in-hospital mortality and 30-day mortality was 1.89 % (n 1). Estimated 5-year survival rate was 95.7 ± 1.45 % for all patients. The average duration of the operations was 291.23 ± 12.67 minutes, the total duration of artificial blood circulation was 170.28 ± 8.77 minutes, aorta clamping time – 122.02 ± 5.92 minutes. The mean duration of stay in the hospital was 13.81 ± 0.54 days, intensive care unit – 2.94 ± 0.03 days. The number of patients extubated up to 8 hours after surgery was 48 patients (90.57 %). The performed operation significantly improved the indicators. Patients positively perceived the information about the absence of an artificial heart valve and need of concomitant use of anticoagulants. The patients had a good psycho-social component, which probably affected the assessment of other scales.Conclusions. Patients after David I operation have a low overall in-hospital mortality and 30-day mortality, with a short period of time in intensive care unit and hospital at all. Long-term results in indicator of 5-year survival are excellent. The operation significantly improves quality of life parameters.
- 26 April 2024
- Published by Chetverta Khvylia in Cardiac Surgery and Interventional Cardiology
- Vol. 13 (1) , 62-67
Open AccessКлапанозбережне протезування кореня аорти: результати операції Девіда І
The aim – to determine the long-term results and quality of life of patients who underwent David І valve-sparing operation.Materials and methods. The one-center study included 53 patients who underwent planned and urgent David I procedure (valve-sparing replacement of the aortic root and ascending aorta) from 2015 to 2023. The mean age of the 53 patients (among them, 47 (88.68 %) males) was 49.11 ± 1.54 years. We analyzed basic characteristics of the patients, intraoperative and postoperative data. The quality of life was assessed before and in the long-term period after operations by the Medical Outcomes Study Short Form 36 (MOS SF-36) questionnaire.Results and discussion. An average duration of the follow-up period was 2.59 ± 0.27 years ranging from 1.0 to 9.0 years. Overall in-hospital mortality and 30-day mortality was 1.89 % (n 1). Estimated 5-year survival rate was 95.7 ± 1.45 % for all patients. The average duration of the operations was 291.23 ± 12.67 minutes, the total duration of artificial blood circulation was 170.28 ± 8.77 minutes, aorta clamping time – 122.02 ± 5.92 minutes. The mean duration of stay in the hospital was 13.81 ± 0.54 days, intensive care unit – 2.94 ± 0.03 days. The number of patients extubated up to 8 hours after surgery was 48 patients (90.57 %). The performed operation significantly improved the indicators. Patients positively perceived the information about the absence of an artificial heart valve and need of concomitant use of anticoagulants. The patients had a good psycho-social component, which probably affected the assessment of other scales.Conclusions. Patients after David I operation have a low overall in-hospital mortality and 30-day mortality, with a short period of time in intensive care unit and hospital at all. Long-term results in indicator of 5-year survival are excellent. The operation significantly improves quality of life parameters.